Gossamer Bio Inc (NASDAQ: GOSS) established initial surge of 11.28% at $2.17, as the Stock market unbolted on Thursday, before settling in for the price of $1.95 at the close. Taking a more long-term approach, GOSS posted a 52-week range of $0.66-$2.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 40.29%. Meanwhile, its Annual Earning per share during the time was 40.29%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -167.09%. This publicly-traded company’s shares outstanding now amounts to $227.32 million, simultaneously with a float of $182.73 million. The organization now has a market capitalization sitting at $493.41 million. At the time of writing, stock’s 50-day Moving Average stood at $1.6300, while the 200-day Moving Average is $1.1700.
Gossamer Bio Inc (GOSS) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Gossamer Bio Inc industry. Gossamer Bio Inc’s current insider ownership accounts for 19.64%, in contrast to 61.50% institutional ownership. According to the most recent insider trade that took place on Aug 19 ’25, this organization’s Director bought 26,050 shares at the rate of 1.92, making the entire transaction reach 50,016 in total value, affecting insider ownership by 58,050.
Gossamer Bio Inc (GOSS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
Gossamer Bio Inc’s EPS decrease for this current 12-month fiscal period is -167.09% and is forecasted to reach -0.47 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 5.92% through the next 5 years, which can be compared against the 40.29% growth it accomplished over the previous five years trading on the market.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Let’s observe the current performance indicators for Gossamer Bio Inc (GOSS). It’s Quick Ratio in the last reported quarter now stands at 4.40. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 12.26.
In the same vein, GOSS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.61, a figure that is expected to reach -0.19 in the next quarter, and analysts are predicting that it will be -0.47 at the market close of one year from today.
Technical Analysis of Gossamer Bio Inc (GOSS)
Now, what If we examine the latest scores posted by [Gossamer Bio Inc, GOSS]. During the last 5-days, its volume was better the volume of 1.95 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 82.01% While, its Average True Range was 68.28%.
Raw Stochastic average of Gossamer Bio Inc (GOSS) in the period of the previous 100 days is set at 95.92%, which indicates a major rise in contrast to 89.38% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1600 that was higher than 0.1200 volatility it exhibited in the past 100-days period.
